Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 638Head and Neck Neoplasms 609Carcinoma, Non-Small-Cell Lung 202Thyroid Neoplasms 200Melanoma 145Nasopharyngeal Carcinoma 136Oropharyngeal Neoplasms 129Colorectal Neoplasms 129Mouth Neoplasms 128Neoplasms 113Breast Neoplasms 112Ovarian Neoplasms 105Lung Neoplasms 105Uterine Cervical Neoplasms 101Neoplasm Metastasis 93Carcinoma, Squamous Cell 86Stomach Neoplasms 84Carcinoma, Renal Cell 84Triple Negative Breast Neoplasms 79Pancreatic Neoplasms 72Esophageal Neoplasms 70Laryngeal Neoplasms 67Endometrial Neoplasms 67Urinary Bladder Neoplasms 61Sarcoma 58Prostatic Neoplasms 55Thyroid Cancer, Papillary 54Salivary Gland Neoplasms 49Carcinoma, Transitional Cell 47Carcinoma, Hepatocellular 46

Interventions

Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Squamous Cell Cancer × Head & Neck × 1 year × Clear all
NCT03138070 2026-01-28

A Window of Opportunity Study to Assess the Modulation of Biomarkers in Head and Neck Squamous Cell Cancer (HNSCC) By Preoperative Treatment With BYL719

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Completed
15 enrolled
Head & Neck

Head and Neck Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡